HEADER VIRAL PROTEIN/INHIBITOR 23-FEB-23 8IHO TITLE CRYSTAL STRUCTURES OF SARS-COV-2 PAPAIN-LIKE PROTEASE IN COMPLEX WITH TITLE 2 COVALENT INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: PAPAIN-LIKE PROTEASE NSP3; COMPND 3 CHAIN: A, C; COMPND 4 SYNONYM: NON-STRUCTURAL PROTEIN 3,NSP3,PL2-PRO,PAPAIN-LIKE COMPND 5 PROTEINASE,PL-PRO; COMPND 6 EC: 3.4.19.12; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: COVALENT INHIBITOR; COMPND 10 CHAIN: D, E; COMPND 11 ENGINEERED: YES; COMPND 12 OTHER_DETAILS: COMMON NAME: LK1 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_TAXID: 2697049; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 SYNTHETIC: YES; SOURCE 9 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 10 ORGANISM_TAXID: 32630 KEYWDS VIRAL PROTEIN-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Q.WANG,H.HU,M.LI,Y.XU REVDAT 1 03-JAN-24 8IHO 0 JRNL AUTH Q.WANG,G.CHEN,J.HE,J.LI,M.XIONG,H.SU,M.LI,H.HU,Y.XU JRNL TITL STRUCTURE-BASED DESIGN OF POTENT PEPTIDOMIMETIC INHIBITORS JRNL TITL 2 COVALENTLY TARGETING SARS-COV-2 PAPAIN-LIKE PROTEASE. JRNL REF INT J MOL SCI V. 24 2023 JRNL REFN ESSN 1422-0067 JRNL PMID 37239980 JRNL DOI 10.3390/IJMS24108633 REMARK 2 REMARK 2 RESOLUTION. 2.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.17.1-3660 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.00 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 32521 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.257 REMARK 3 R VALUE (WORKING SET) : 0.254 REMARK 3 FREE R VALUE : 0.305 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.860 REMARK 3 FREE R VALUE TEST SET COUNT : 1581 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 45.0000 - 5.6700 0.99 2985 156 0.2257 0.3096 REMARK 3 2 5.6700 - 4.5000 1.00 2878 134 0.2160 0.2521 REMARK 3 3 4.5000 - 3.9300 1.00 2822 137 0.2183 0.2535 REMARK 3 4 3.9300 - 3.5700 1.00 2800 159 0.2451 0.2992 REMARK 3 5 3.5700 - 3.3200 1.00 2778 150 0.2675 0.3020 REMARK 3 6 3.3100 - 3.1200 1.00 2801 130 0.2876 0.3651 REMARK 3 7 3.1200 - 2.9600 1.00 2793 147 0.2973 0.3439 REMARK 3 8 2.9600 - 2.8300 1.00 2759 143 0.3023 0.3366 REMARK 3 9 2.8300 - 2.7300 1.00 2787 139 0.3203 0.3658 REMARK 3 10 2.7300 - 2.6300 1.00 2749 155 0.3347 0.3613 REMARK 3 11 2.6300 - 2.5500 1.00 2788 131 0.3784 0.4079 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.430 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.820 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 5009 REMARK 3 ANGLE : 0.659 6806 REMARK 3 CHIRALITY : 0.045 758 REMARK 3 PLANARITY : 0.003 863 REMARK 3 DIHEDRAL : 8.768 716 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8IHO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 06-MAR-23. REMARK 100 THE DEPOSITION ID IS D_1300035274. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-NOV-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32601 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.550 REMARK 200 RESOLUTION RANGE LOW (A) : 89.780 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 10.80 REMARK 200 R MERGE (I) : 0.14400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.69 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 10.00 REMARK 200 R MERGE FOR SHELL (I) : 1.02000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M SODIUM BROMIDE, 20% W/V PEG REMARK 280 3350, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 59.31450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 29.78550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 68.67500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 29.78550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 59.31450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 68.67500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 GLU A 1 REMARK 465 LYS A 315 REMARK 465 MET C 0 REMARK 465 GLU C 1 REMARK 465 VAL C 2 REMARK 465 ARG C 3 REMARK 465 MET C 25 REMARK 465 THR C 26 REMARK 465 TYR C 27 REMARK 465 GLY C 28 REMARK 465 LYS C 315 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 22 CG OD1 OD2 REMARK 470 SER A 24 OG REMARK 470 GLN A 29 CG CD OE1 NE2 REMARK 470 ASP A 61 CG OD1 OD2 REMARK 470 LYS A 126 CG CD CE NZ REMARK 470 LYS C 6 CG CD CE NZ REMARK 470 VAL C 11 CG1 CG2 REMARK 470 ASP C 12 CG OD1 OD2 REMARK 470 ASN C 13 CG OD1 ND2 REMARK 470 ILE C 14 CG1 CG2 CD1 REMARK 470 VAL C 20 CG1 CG2 REMARK 470 VAL C 21 CG1 CG2 REMARK 470 ASP C 22 CG OD1 OD2 REMARK 470 MET C 23 CG SD CE REMARK 470 SER C 24 OG REMARK 470 GLN C 29 CG CD OE1 NE2 REMARK 470 GLN C 30 CG CD OE1 NE2 REMARK 470 PHE C 31 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS C 45 CG CD CE NZ REMARK 470 VAL C 57 CG1 CG2 REMARK 470 LEU C 58 CG CD1 CD2 REMARK 470 ASN C 60 CG OD1 ND2 REMARK 470 ASP C 61 CG OD1 OD2 REMARK 470 ASP C 62 CG OD1 OD2 REMARK 470 THR C 63 OG1 CG2 REMARK 470 LEU C 64 CG CD1 CD2 REMARK 470 ARG C 65 CG CD NE CZ NH1 NH2 REMARK 470 GLU C 70 CG CD OE1 OE2 REMARK 470 THR C 225 OG1 CG2 REMARK 470 LYS C 228 CG CD CE NZ REMARK 470 LYS C 279 CG CD CE NZ REMARK 470 LEU C 289 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 SG CYS C 111 CB GVE E 104 1.80 REMARK 500 SG CYS A 111 CB GVE D 104 1.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 107 125.45 -172.78 REMARK 500 LYS A 279 -125.82 -120.88 REMARK 500 ASN A 308 -80.50 -117.69 REMARK 500 SER C 103 -163.84 -111.77 REMARK 500 ALA C 107 128.39 -171.70 REMARK 500 THR C 259 -66.09 -94.02 REMARK 500 LYS C 279 -128.92 -115.31 REMARK 500 ASP C 286 -83.16 -83.70 REMARK 500 ASN C 308 -62.76 -128.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY D 102 GLY D 103 132.85 REMARK 500 GLY E 102 GLY E 103 126.62 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 401 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 189 SG REMARK 620 2 CYS A 192 SG 152.0 REMARK 620 3 CYS A 224 SG 118.1 79.8 REMARK 620 4 CYS A 226 SG 94.0 77.4 144.6 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN C 401 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS C 189 SG REMARK 620 2 CYS C 192 SG 91.7 REMARK 620 3 CYS C 224 SG 124.8 105.1 REMARK 620 4 CYS C 226 SG 84.8 122.7 123.4 REMARK 620 N 1 2 3 DBREF 8IHO A 1 315 UNP P0DTC1 R1A_SARS2 1564 1878 DBREF 8IHO C 1 315 UNP P0DTC1 R1A_SARS2 1564 1878 DBREF 8IHO D 101 104 PDB 8IHO 8IHO 101 104 DBREF 8IHO E 101 104 PDB 8IHO 8IHO 101 104 SEQADV 8IHO MET A 0 UNP P0DTC1 INITIATING METHIONINE SEQADV 8IHO MET C 0 UNP P0DTC1 INITIATING METHIONINE SEQRES 1 A 316 MET GLU VAL ARG THR ILE LYS VAL PHE THR THR VAL ASP SEQRES 2 A 316 ASN ILE ASN LEU HIS THR GLN VAL VAL ASP MET SER MET SEQRES 3 A 316 THR TYR GLY GLN GLN PHE GLY PRO THR TYR LEU ASP GLY SEQRES 4 A 316 ALA ASP VAL THR LYS ILE LYS PRO HIS ASN SER HIS GLU SEQRES 5 A 316 GLY LYS THR PHE TYR VAL LEU PRO ASN ASP ASP THR LEU SEQRES 6 A 316 ARG VAL GLU ALA PHE GLU TYR TYR HIS THR THR ASP PRO SEQRES 7 A 316 SER PHE LEU GLY ARG TYR MET SER ALA LEU ASN HIS THR SEQRES 8 A 316 LYS LYS TRP LYS TYR PRO GLN VAL ASN GLY LEU THR SER SEQRES 9 A 316 ILE LYS TRP ALA ASP ASN ASN CYS TYR LEU ALA THR ALA SEQRES 10 A 316 LEU LEU THR LEU GLN GLN ILE GLU LEU LYS PHE ASN PRO SEQRES 11 A 316 PRO ALA LEU GLN ASP ALA TYR TYR ARG ALA ARG ALA GLY SEQRES 12 A 316 GLU ALA ALA ASN PHE CYS ALA LEU ILE LEU ALA TYR CYS SEQRES 13 A 316 ASN LYS THR VAL GLY GLU LEU GLY ASP VAL ARG GLU THR SEQRES 14 A 316 MET SER TYR LEU PHE GLN HIS ALA ASN LEU ASP SER CYS SEQRES 15 A 316 LYS ARG VAL LEU ASN VAL VAL CYS LYS THR CYS GLY GLN SEQRES 16 A 316 GLN GLN THR THR LEU LYS GLY VAL GLU ALA VAL MET TYR SEQRES 17 A 316 MET GLY THR LEU SER TYR GLU GLN PHE LYS LYS GLY VAL SEQRES 18 A 316 GLN ILE PRO CYS THR CYS GLY LYS GLN ALA THR LYS TYR SEQRES 19 A 316 LEU VAL GLN GLN GLU SER PRO PHE VAL MET MET SER ALA SEQRES 20 A 316 PRO PRO ALA GLN TYR GLU LEU LYS HIS GLY THR PHE THR SEQRES 21 A 316 CYS ALA SER GLU TYR THR GLY ASN TYR GLN CYS GLY HIS SEQRES 22 A 316 TYR LYS HIS ILE THR SER LYS GLU THR LEU TYR CYS ILE SEQRES 23 A 316 ASP GLY ALA LEU LEU THR LYS SER SER GLU TYR LYS GLY SEQRES 24 A 316 PRO ILE THR ASP VAL PHE TYR LYS GLU ASN SER TYR THR SEQRES 25 A 316 THR THR ILE LYS SEQRES 1 C 316 MET GLU VAL ARG THR ILE LYS VAL PHE THR THR VAL ASP SEQRES 2 C 316 ASN ILE ASN LEU HIS THR GLN VAL VAL ASP MET SER MET SEQRES 3 C 316 THR TYR GLY GLN GLN PHE GLY PRO THR TYR LEU ASP GLY SEQRES 4 C 316 ALA ASP VAL THR LYS ILE LYS PRO HIS ASN SER HIS GLU SEQRES 5 C 316 GLY LYS THR PHE TYR VAL LEU PRO ASN ASP ASP THR LEU SEQRES 6 C 316 ARG VAL GLU ALA PHE GLU TYR TYR HIS THR THR ASP PRO SEQRES 7 C 316 SER PHE LEU GLY ARG TYR MET SER ALA LEU ASN HIS THR SEQRES 8 C 316 LYS LYS TRP LYS TYR PRO GLN VAL ASN GLY LEU THR SER SEQRES 9 C 316 ILE LYS TRP ALA ASP ASN ASN CYS TYR LEU ALA THR ALA SEQRES 10 C 316 LEU LEU THR LEU GLN GLN ILE GLU LEU LYS PHE ASN PRO SEQRES 11 C 316 PRO ALA LEU GLN ASP ALA TYR TYR ARG ALA ARG ALA GLY SEQRES 12 C 316 GLU ALA ALA ASN PHE CYS ALA LEU ILE LEU ALA TYR CYS SEQRES 13 C 316 ASN LYS THR VAL GLY GLU LEU GLY ASP VAL ARG GLU THR SEQRES 14 C 316 MET SER TYR LEU PHE GLN HIS ALA ASN LEU ASP SER CYS SEQRES 15 C 316 LYS ARG VAL LEU ASN VAL VAL CYS LYS THR CYS GLY GLN SEQRES 16 C 316 GLN GLN THR THR LEU LYS GLY VAL GLU ALA VAL MET TYR SEQRES 17 C 316 MET GLY THR LEU SER TYR GLU GLN PHE LYS LYS GLY VAL SEQRES 18 C 316 GLN ILE PRO CYS THR CYS GLY LYS GLN ALA THR LYS TYR SEQRES 19 C 316 LEU VAL GLN GLN GLU SER PRO PHE VAL MET MET SER ALA SEQRES 20 C 316 PRO PRO ALA GLN TYR GLU LEU LYS HIS GLY THR PHE THR SEQRES 21 C 316 CYS ALA SER GLU TYR THR GLY ASN TYR GLN CYS GLY HIS SEQRES 22 C 316 TYR LYS HIS ILE THR SER LYS GLU THR LEU TYR CYS ILE SEQRES 23 C 316 ASP GLY ALA LEU LEU THR LYS SER SER GLU TYR LYS GLY SEQRES 24 C 316 PRO ILE THR ASP VAL PHE TYR LYS GLU ASN SER TYR THR SEQRES 25 C 316 THR THR ILE LYS SEQRES 1 D 4 PQX GLY GLY GVE SEQRES 1 E 4 PQX GLY GLY GVE HET PQX D 101 20 HET GVE D 104 8 HET PQX E 101 20 HET GVE E 104 8 HET ZN A 401 1 HET ZN C 401 1 HETNAM PQX 1-[(1R)-1-NAPHTHALEN-1-YLETHYL]PIPERIDINE-4-CARBOXYLIC HETNAM 2 PQX ACID HETNAM GVE METHYL 4-AMINOBUTANOATE HETNAM ZN ZINC ION FORMUL 3 PQX 2(C18 H21 N O2) FORMUL 3 GVE 2(C5 H11 N O2) FORMUL 5 ZN 2(ZN 2+) HELIX 1 AA1 TYR A 27 GLY A 32 1 6 HELIX 2 AA2 HIS A 47 GLU A 51 5 5 HELIX 3 AA3 ASP A 61 HIS A 73 1 13 HELIX 4 AA4 PRO A 77 LYS A 91 1 15 HELIX 5 AA5 ASN A 110 GLN A 121 1 12 HELIX 6 AA6 PRO A 129 ALA A 141 1 13 HELIX 7 AA7 ALA A 144 CYS A 155 1 12 HELIX 8 AA8 ASP A 164 HIS A 175 1 12 HELIX 9 AA9 GLY A 201 VAL A 205 1 5 HELIX 10 AB1 SER A 212 GLY A 219 1 8 HELIX 11 AB2 HIS C 47 GLU C 51 5 5 HELIX 12 AB3 ASP C 61 HIS C 73 1 13 HELIX 13 AB4 PRO C 77 LYS C 91 1 15 HELIX 14 AB5 ASN C 110 GLN C 121 1 12 HELIX 15 AB6 PRO C 129 ALA C 141 1 13 HELIX 16 AB7 ALA C 144 CYS C 155 1 12 HELIX 17 AB8 ASP C 164 HIS C 175 1 12 HELIX 18 AB9 VAL C 202 ALA C 204 5 3 HELIX 19 AC1 SER C 212 GLY C 219 1 8 SHEET 1 AA1 5 HIS A 17 ASP A 22 0 SHEET 2 AA1 5 THR A 4 THR A 10 -1 N ILE A 5 O VAL A 21 SHEET 3 AA1 5 THR A 54 VAL A 57 1 O PHE A 55 N PHE A 8 SHEET 4 AA1 5 THR A 34 LEU A 36 -1 N TYR A 35 O TYR A 56 SHEET 5 AA1 5 ALA A 39 ASP A 40 -1 O ALA A 39 N LEU A 36 SHEET 1 AA2 2 GLN A 97 VAL A 98 0 SHEET 2 AA2 2 LEU A 101 THR A 102 -1 O LEU A 101 N VAL A 98 SHEET 1 AA3 4 GLY A 193 LYS A 200 0 SHEET 2 AA3 4 LYS A 182 CYS A 189 -1 N ARG A 183 O LEU A 199 SHEET 3 AA3 4 GLN A 229 GLU A 238 -1 O VAL A 235 N VAL A 184 SHEET 4 AA3 4 VAL A 220 PRO A 223 -1 N ILE A 222 O ALA A 230 SHEET 1 AA4 4 GLY A 193 LYS A 200 0 SHEET 2 AA4 4 LYS A 182 CYS A 189 -1 N ARG A 183 O LEU A 199 SHEET 3 AA4 4 GLN A 229 GLU A 238 -1 O VAL A 235 N VAL A 184 SHEET 4 AA4 4 SER A 309 THR A 311 -1 O TYR A 310 N GLN A 237 SHEET 1 AA5 7 MET A 206 MET A 208 0 SHEET 2 AA5 7 PHE A 241 LEU A 253 1 O SER A 245 N TYR A 207 SHEET 3 AA5 7 TYR A 296 LYS A 306 -1 O VAL A 303 N MET A 244 SHEET 4 AA5 7 CYS A 260 GLY A 266 -1 N CYS A 260 O PHE A 304 SHEET 5 AA5 7 GLY A 271 SER A 278 -1 O LYS A 274 N GLU A 263 SHEET 6 AA5 7 LEU A 282 ASP A 286 -1 O ILE A 285 N HIS A 275 SHEET 7 AA5 7 LEU A 289 SER A 293 -1 O LEU A 289 N ASP A 286 SHEET 1 AA6 5 HIS C 17 VAL C 21 0 SHEET 2 AA6 5 ILE C 5 THR C 10 -1 N ILE C 5 O VAL C 21 SHEET 3 AA6 5 THR C 54 VAL C 57 1 O PHE C 55 N PHE C 8 SHEET 4 AA6 5 THR C 34 LEU C 36 -1 N TYR C 35 O TYR C 56 SHEET 5 AA6 5 ALA C 39 ASP C 40 -1 O ALA C 39 N LEU C 36 SHEET 1 AA7 2 GLN C 97 VAL C 98 0 SHEET 2 AA7 2 LEU C 101 THR C 102 -1 O LEU C 101 N VAL C 98 SHEET 1 AA8 4 GLY C 193 LYS C 200 0 SHEET 2 AA8 4 LYS C 182 CYS C 189 -1 N ARG C 183 O LEU C 199 SHEET 3 AA8 4 GLN C 229 GLU C 238 -1 O GLU C 238 N LYS C 182 SHEET 4 AA8 4 VAL C 220 PRO C 223 -1 N ILE C 222 O ALA C 230 SHEET 1 AA9 4 GLY C 193 LYS C 200 0 SHEET 2 AA9 4 LYS C 182 CYS C 189 -1 N ARG C 183 O LEU C 199 SHEET 3 AA9 4 GLN C 229 GLU C 238 -1 O GLU C 238 N LYS C 182 SHEET 4 AA9 4 SER C 309 THR C 311 -1 O TYR C 310 N GLN C 237 SHEET 1 AB1 7 MET C 206 MET C 208 0 SHEET 2 AB1 7 PHE C 241 LEU C 253 1 O SER C 245 N TYR C 207 SHEET 3 AB1 7 TYR C 296 LYS C 306 -1 O VAL C 303 N MET C 244 SHEET 4 AB1 7 CYS C 260 GLY C 266 -1 N SER C 262 O THR C 301 SHEET 5 AB1 7 GLY C 271 SER C 278 -1 O LYS C 274 N GLU C 263 SHEET 6 AB1 7 LEU C 282 ILE C 285 -1 O ILE C 285 N HIS C 275 SHEET 7 AB1 7 LEU C 290 SER C 293 -1 O SER C 293 N LEU C 282 LINK C7 PQX D 101 N GLY D 102 1555 1555 1.33 LINK C GLY D 103 N GVE D 104 1555 1555 1.33 LINK C7 PQX E 101 N GLY E 102 1555 1555 1.34 LINK C GLY E 103 N GVE E 104 1555 1555 1.32 LINK SG CYS A 189 ZN ZN A 401 1555 1555 2.80 LINK SG CYS A 192 ZN ZN A 401 1555 1555 2.76 LINK SG CYS A 224 ZN ZN A 401 1555 1555 2.65 LINK SG CYS A 226 ZN ZN A 401 1555 1555 2.44 LINK SG CYS C 189 ZN ZN C 401 1555 1555 2.58 LINK SG CYS C 192 ZN ZN C 401 1555 1555 2.46 LINK SG CYS C 224 ZN ZN C 401 1555 1555 2.46 LINK SG CYS C 226 ZN ZN C 401 1555 1555 2.41 CISPEP 1 GLY D 103 GVE D 104 0 11.44 CRYST1 118.629 137.350 59.571 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008430 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007281 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016787 0.00000